CALGB 90206 was a phase III trial of 732 mRCC patients comparing bevacizumab plus interferon alpha (BEV+IFN) versus interferon alpha alone (IFN). No difference in overall survival (OS) was observed.
To report 5- and 7-year outcomes after image-guided moderately accelerated hypofractionated proton therapy (AHPT) for prostate cancer. We reviewed the first 582 prostate cancer patients enrolled on prospective outcomes tracking trial and treated with double-scattered moderately AHPT between 2008 and 2015.
The clinical impact of concurrent corticosteroid use (CCU) on enzalutamide-treated patients with metastatic castration-resistant prostate cancer (mCRPC) is unknown. We investigated the association of CCU with overall survival (OS), radiographic progression-free survival (rPFS), and time to prostate-specific antigen progression (TTPP) in post-chemotherapy, enzalutamide-treated patients with mCRPC.
Prostate cancer survivors are increasingly turning to online communities for support. This study explored predictors of and barriers to use. A prospective survey of 141 Australian prostate cancer survivors assessed sociodemographic, clinical, psychosocial, and attitudinal characteristics associated with intention to use, and subsequent use of online communities.
or objectives The FLAME trial (NCT01168479) showed that by adding a focal boost to conventional fractionated EBRT in the treatment of localized prostate cancer, the five-year biochemical disease-free survival increased, without significantly increasing toxicity.
To examine the effect of veteran status on prostate-specific antigen (PSA) screening and whether health coverage available to veterans mitigates racial disparities in PSA screening. A cross-sectional analysis of non-Hispanic White (NHW) and non-Hispanic Black (NHB) men aged 55-69 who responded to the PSA screening survey in the 2018 Behavioral Risk Factor Surveillance System data […]
Up to 14% of bladder urothelial carcinoma has variant histology (VH), which is associated with a higher incidence of occult regional lymph node metastasis. Neoadjuvant chemotherapy (NAC) is the gold-standard for resectable cT2-4 disease as it achieves pathologic complete response (pCR) in select patients at the time of radical cystectomy (RC).
(1) Aim: Robot assisted radical cystectomy (RARC) with intacorporeal neobladder (iN) is a challenging procedure. There is a paucity of reports on RARC-iN, the extracorporeal approach being the most used.
To assess the impact of lifetime obesity on the development of urinary incontinence (UI). Using data from the Women’s Health Initiative (WHI), we evaluated the cumulative impact of obesity over a postmenopausal woman’s lifetime on the development of UI.
Reconstructive approaches for distal urethral strictures range from simple meatotomy to utilizing grafts or flaps depending on the etiology, length and location. We describe a contemporary cohort of distal urethral strictures and report a surgical technique termed distal one-stage urethroplasty developed to address the majority of distal urethral strictures encountered.
